SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is currently under significant downward pressure as investors react to the start of a landmark trial involving 29 states, which focuses on allegations that the company's platforms harm younger users. While the community is deeply divided between those viewing the legal risk as an existential threat to the ad-based business model and value investors who see the current dip as a buying opportunity, the ongoing uncertainty remains a primary driver of volatility.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is attracting significant attention as investors monitor institutional inflows and potential shifts in crypto regulation, despite ongoing debates about its price direction and long-term utility. The community remains deeply divided, with some traders actively looking for a bullish breakout from current consolidation levels while others express skepticism, citing macro uncertainties and historical cycle patterns.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is seeing heightened trading volume and speculative interest as retail investors weigh whether the stock represents a deep-value opportunity or a long-term turnaround play. Community discussion is polarized, focusing on potential leadership changes, competition in the athleisure sector, and the stock's performance as a contrarian hedge against volatility in the tech and AI-focused markets.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is facing significant downward pressure as investors react to a downward revision in revenue guidance and news of an upcoming leadership transition. Despite a strong underlying business performance, the community remains divided between those viewing the pullback as a buying opportunity to capitalize on long-term growth and those expressing frustration over the stock's volatility and recent performance.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is experiencing heightened volatility and intense debate following underwhelming earnings guidance that has triggered widespread skepticism regarding the company's long-term profitability and debt management. The community remains deeply divided, with bearish voices highlighting investigative scrutiny and alleged financial irregularities, while bulls continue to focus on the potential for short-squeeze momentum and long-term turnaround narratives.

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals is trending following positive topline results from its Phase 3 LUCIDITY trial, where avexitide demonstrated a significant reduction in severe hypoglycemic events. Investors are actively discussing the potential for a regulatory submission by year-end, the company's strong cash position, and the possibility of a buyout as market sentiment shifts toward the company's de-risked clinical pipeline.

Fabrinet engages in the provision of optical packaging and electronic manufacturing services to original equipment manufacturers. The firm's engineering services include process design, failure analysis, reliability testing, tooling design, and real-time traceability system. Its manufacturing operations offer sensors, subsystems, customized optics, and optical modules and components. The company was founded by David Thomas Mitchell on August 12, 1999 and is headquartered in George Town, Cayman Islands.

Fabrinet

Fabrinet shares are experiencing significant volatility following an earnings report that featured a beat on both top and bottom lines alongside raised guidance. Investors are actively debating whether the decline is a genuine fundamental reaction to inventory and margin pressures or a temporary overreaction driven by algorithmic trading and broader sector weakness.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is capturing investor interest as a specialized edge data center player that provides modular, rapid-deployment infrastructure to meet the exploding demand for AI compute. The stock is being closely watched as the company scales its high-density GPU hosting capacity and secures long-term contracted revenue, positioning it as a distinct alternative to larger, supply-constrained hyperscale projects.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is trending as investors react to a significant post-earnings sell-off driven by a revenue miss and continued pressure on its legacy advertising business. While community sentiment remains polarized, many are closely watching whether the company's aggressive pivot toward AI cloud infrastructure and its potential chip unit IPO can eventually offset these headwinds.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is experiencing intense volatility as shares hit multi-year lows, fueling a heated community debate between value-oriented investors looking for a generational turnaround and bears citing poor execution and shifting consumer brand preferences. While some market participants are capitalizing on the aggressive sell-off to build positions, others are actively betting against the legacy athletic giant, highlighting concerns over management's strategic direction and increasing competition in the sportswear sector.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why You Should Retain CONMED Stock in Your Portfolio Now

CONMED's growth outlook is supported by Buffalo Filter, BioBrace and organic momentum, though slower AirSeal growth and tariffs remain key risks.

Here is Why Growth Investors Should Buy Globus Medical (GMED) Now 

Globus Medical (GMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Natera Supports Kupando Trial to Advance ctDNA Monitoring in Cancer

NTRA is using its Latitude MRD test in Kupando's Phase 1 skin cancer trial to track ctDNA and characterize response to KUP-101.

iRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform

IRTC's VitalConnect deal expands its cardiac monitoring reach across ambulatory, inpatient and hospital-to-home care while opening new growth opportunities.

Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its growth prospects.

Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs

RVTY launches SuperFlex, a compact automated prenatal screening system aimed at expanding rapid in-house testing for smaller labs and clinics.

ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?

ISRG's US procedure growth slows in Q2, but ACA-related care deferrals may prove temporary as underlying demand and da Vinci 5 adoption remain strong.

Here's Why You Should Add BrightSpring Stock to Your Portfolio Now

BTSG's specialty, infusion and home health momentum support growth, while IRA pressure and customer exits may weigh on near-term margins.

NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up

NeuroPace's Q2 revenues rise 17.1% as RNS demand strengthens, while a narrower loss and higher 2026 outlook highlight continued momentum.

CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up

Cardinal Health beats fiscal Q4 EPS estimates as profit surges, while revenues miss; fiscal 2027 guidance points to continued earnings growth.

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. The firm classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in 2003 and is headquartered in Audubon, PA.

Globus Medical Inc - Ordinary Shares - Class A

Wall Street Upgrades: Arm Holdings, Upstart, Globus Medical Get Analyst Cheer, Retail Bullish On Just Two Names

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$87.10
Prev Close	$85.12
Open	$85.50
Dividend Yield	0.00%
50-Day Moving Average	$80.11
Beta	0.91
Avg. Volume	1.69M
PE Ratio	21.77

52-Week High	$101.40
52-Week Low	$54.15
Market Capitalization	$11.43B
EPS (Annual)	$3.92
Price to Book	2.40
Revenue Per Employee	$489,821.83

Feed

News

Sentiment

Earnings

Fundamentals

Info